This content is machine translated Small cell lung carcinoma Regulatory extension for durvalumab Durvalumab was approved EU-wide in combination with chemotherapy of etoposide plus either cisplatin or carboplatin followed by durvalumab maintenance therapy for the first-line treatment of adults with advanced-stage small cell…
View Post 12 min This content is machine translated Skin carcinomas of the head and neck Tips and tricks for the surgical procedure Prior to reconstruction, the detected skin lesions should always be examined histologically. There are a number of things to consider during a surgical procedure, including adequate instrumentation and consideration of…
View Post 8 min This content is machine translated Urothelial carcinoma of the urinary bladder A challenge even in times of immune checkpoint inhibitors Urothelial carcinoma accounts for 90% of urinary bladder tumors. Every year, 1250 people in Switzerland contract the disease – predominantly older men. Standard treatment is cisplatin-containing chemotherapy. Immunotherapy is playing…
View Post 3 min This content is machine translated Pediatric Oncology No cancer like any other: when life stops Cancer in childhood and adolescence places special demands on both those affected and the physicians treating them. Specialized, interdisciplinary centers therefore work closely in defined infrastructures to ensure the survival…
View Post 2 min This content is machine translated Antiemesis Effectively counteract chemotherapy-induced nausea and vomiting As one of the most important treatment options for malignant diseases, chemotherapy remains the focus of many therapeutic regimens. However, cisplatin-based treatment in particular is considered highly emetogenic. Nausea and…
View Post 4 min This content is machine translated Pain Medicine Recognize and effectively treat tumor-related breakthrough pain Tumor breakthrough pain is very common in patients with malignancies. Yet they are often overlooked or misjudged. However, the sudden and severe attacks of pain put a strain on sufferers…
View Post 3 min This content is machine translated Ovarian Cancer Updated S3 guideline recommends PARP inhibitors and radiotherapy Because ovarian cancer generally has no specific symptoms, it is often diagnosed at late stages. The mortality risk is correspondingly high. In order to provide affected women with optimal therapy,…
View Post 1 min This content is machine translated Precision Oncology First drug with tumor-independent indication approved New paths are being taken in cancer therapy. Precision oncology opens up the possibility of tailoring treatment no longer to the localization of the tumor, but to its cross-tissue molecular…
View Post 8 min This content is machine translated Actinic keratoses Current overview of a widespread dermatosis Actinic keratoses are a marker of chronic sun damage and carcinogenesis of the skin. Sun protection, especially at a young age, is the most important primary prevention measure against actinic…
View Post 1 min This content is machine translated Cutaneous squamous cell carcinoma First systemic therapy approved Patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation can now be treated with immunotherapy for the first time.…
View Post 2 min This content is machine translated Bladder Cancer Immunotherapy after chemo may prolong survival Carcinoma of the urinary bladder is one of the common malignant diseases. While the prognosis of patients with superficial tumors is usually favorable, the situation is much worse for muscle-infiltrating…
